STOCKS NEWS US-Vical shares up after results of study

Tue Jun 30, 2009 9:14am EDT
 
[-] Text [+]
 Stocks on the move [HOT-RTRS]
 Real-time Equity news [U][E][RESF/US]
 For U.S. stock market report double-click [.N]
0909 ET 30June2009-Vical shares up after results of study
------------------------------------------------------------------------------
 Shares of Vical Inc (VICL.O) surged in premarket trading on Tuesday, after
the company said its vaccine against the H1N1 strain of influenza virus showed
positive immune response in preclinical study.
 The vaccine candidate produced robust immune responses well above the
accepted protection threshold in all the vaccinated mice and rabbits after a
standard two-dose vaccine regimen, Vical said.
 For details, see [ID:nBNG479155]
 Shares soared 28.2 percent to $2.82 in premarket trading.
 Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0907 ET 30June2009-NYC economy shrinks in June: NY NAPM
------------------------------------------------------------------------------
 Business activity in New York City returned to contraction in June after
briefly expanding in May, according to an industry report released on Tuesday.
 The National Association of Purchasing Management-New York said its index
of local business conditions fell to 359.0 in June from 361.6 the previous
month.
 NAPM's report also said its index of current business conditions fell to
44.8 in June from 61.3 in May. The 50 level separates growth from contraction.
 For details, see [ID:nNYS005186]
 Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0903 ET 30June2009-April home prices fell, pace moderated: S&P
------------------------------------------------------------------------------
 Prices of U.S. single-family homes declined in April from the prior month,
but the pace of the decline moderated, suggesting stability is emerging in some
regions, according to Standard & Poor's/Case Shiller home price indexes
 reported on Tuesday.
 The index of 20 metropolitan areas dipped 0.6 percent in April from March,
after a 2.2 percent decline the month before, for an 18.1 percent downturn from
a year earlier.
 For details, see [ID:nNYS005189]
 Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0844 ET 30June2009-Bove raises price target on State Street
------------------------------------------------------------------------------
 Rochdale Securities analyst Richard Bove on Tuesday raised his price target
on State Street Corp (STT.N), lifting it to $60 from $52.
 Bove noted that the company had elected to redeem its TARP
 preferred, a move he said would eventually add 7 cents a share to the
company's quarterly earnings.
 "More important," he added, "business is good. Money is now pouring into
mutual funds again. The equity markets are up. There are more debt offerings.
State Street is adding to its customer list constantly. Funds in custody are
believed to be rising. If the markets hold, funds under management will rise."
 Shares of State Street edged 0.3 percent higher to $48.65 in premarket
trading.
 Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0842 ET 30June2009-Pfizer offers EU remedies over planned Wyeth deal
------------------------------------------------------------------------------
 Pfizer (PFE.N) has offered remedies aimed at tackling concerns that its $68
billion planned takeover of rival Wyeth WYE.N may be anti-competitive, the
European Commission said on Tuesday.
 The Commission, which polices competition in the 27-country European Union,
said in a daily list of planned mergers under scrutiny that it had extended the
deadline for its review of the deal to July 20 from July 6. It gave no further
details.
 For details, see [ID:nLU646603]
 Shares of Pfizer, a Dow component, closed Monday at $15.26 while Wyeth
closed at $45.35.
 Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net

 

Featured Broker sponsored link